A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

NCT02758496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2017-05-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Conditions

  • Autistic Disorder

Interventions

OTHER

MeRT Efficacy Chart Review

There will be not intervention. This is a chart review.

Sponsors & Collaborators

  • Wave Neuroscience

    lead INDUSTRY

Principal Investigators

  • Keun-Young Kim, MD · Brain Treatment Center

Eligibility

Min Age
2 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758496 on ClinicalTrials.gov